Literature DB >> 30354756

Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma.

Yuto Yamazaki1, Kei Omata2,3,4, Yuta Tezuka2,3, Yoshikiyo Ono3,5, Ryo Morimoto3, Yuzu Adachi6, Kazue Ise1,7, Yasuhiro Nakamura1,7, Celso E Gomez-Sanchez8,9, Yukiko Shibahara10, Takumi Kitamoto11,12, Tetsuo Nishikawa11, Sadayoshi Ito3, Fumitoshi Satoh2,3, Hironobu Sasano1.   

Abstract

Aldosterone-producing adenomas (APAs) harbor marked intratumoral heterogeneity in terms of morphology, steroidogenesis, and genetics. However, an association of biological significance of morphologically identified tumor cell subtypes and genotypes is virtually unknown. KCNJ5 mutation is most frequently detected and generally considered a curable phenotype by adrenalectomy. Therefore, to explore the biological significance of KCNJ5 mutation in APA based on intracellular hormonal activities, 35 consecutively selected APAs (n=18; KCNJ5 mutated, n=17; wild type) were quantitatively examined in the whole tumor areas by newly developed digital image analysis incorporating their histological and ultrastructural features (14 cells from 2 KCNJ5-mutated APAs and 15 cells from 1 wild type) and CYP11B2 immunoreactivity. Results demonstrated that KCNJ5-mutated APAs had significantly lower nuclear/cytoplasm ratio and more abundant clear cells than wild type. CYP11B2 immunoreactivity was not significantly different between these genotypes, but a significant correlation was detected between the proportion of clear cells and CYP11B2 immunoreactivity in all of the APAs examined. CYP11B2 was predominantly immunolocalized in clear cells in KCNJ5-mutated APAs. Quantitative ultrastructural analysis revealed that KCNJ5-mutated APAs had significantly more abundant and smaller-sized mitochondria with well-developed cristae than wild type, whereas wild type had more abundant lipid droplets per unit area despite the small number of the cases examined. Our results did provide the novel insights into the morphological features of APA based on their biological significance. KCNJ5-mutated APAs were characterized by predominance of enlarged lipid-rich clear cells possibly resulting in increased neoplastic aldosterone biosynthesis.

Entities:  

Keywords:  adrenocortical adenoma; aldosterone; cytochrome P-450 CYP11B2; hyperaldosteronism; immunohistochemistry; mitochondria; mutation

Mesh:

Substances:

Year:  2018        PMID: 30354756      PMCID: PMC6759988          DOI: 10.1161/HYPERTENSIONAHA.118.10907

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  36 in total

1.  Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.

Authors:  Ryo Taguchi; Masanobu Yamada; Yasuyo Nakajima; Tetsurou Satoh; Koshi Hashimoto; Nobuyuki Shibusawa; Atsushi Ozawa; Shuichi Okada; Nana Rokutanda; Daisuke Takata; Yukio Koibuchi; Jun Horiguchi; Tetsunari Oyama; Izumi Takeyoshi; Masatomo Mori
Journal:  J Clin Endocrinol Metab       Date:  2012-01-25       Impact factor: 5.958

2.  Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors.

Authors:  Elena A B Azizan; Brian Y H Lam; Stephen J Newhouse; Junhua Zhou; Rhoda E Kuc; Jennifer Clarke; Lisa Happerfield; Alison Marker; Gary J Hoffman; Morris J Brown
Journal:  J Clin Endocrinol Metab       Date:  2012-03-22       Impact factor: 5.958

3.  Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.

Authors:  Felix Beuschlein; Sheerazed Boulkroun; Andrea Osswald; Thomas Wieland; Hang N Nielsen; Urs D Lichtenauer; David Penton; Vivien R Schack; Laurence Amar; Evelyn Fischer; Anett Walther; Philipp Tauber; Thomas Schwarzmayr; Susanne Diener; Elisabeth Graf; Bruno Allolio; Benoit Samson-Couterie; Arndt Benecke; Marcus Quinkler; Francesco Fallo; Pierre-Francois Plouin; Franco Mantero; Thomas Meitinger; Paolo Mulatero; Xavier Jeunemaitre; Richard Warth; Bente Vilsen; Maria-Christina Zennaro; Tim M Strom; Martin Reincke
Journal:  Nat Genet       Date:  2013-02-17       Impact factor: 38.330

Review 4.  Role of mitochondria in steroidogenesis.

Authors:  Vassilios Papadopoulos; Walter L Miller
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-06-16       Impact factor: 4.690

5.  A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.

Authors:  Gian Paolo Rossi; Giampaolo Bernini; Chiara Caliumi; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Chiara Ganzaroli; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Massimo Mannelli; Mee-Jung Mattarello; Angelica Moretti; Gaetana Palumbo; Gabriele Parenti; Enzo Porteri; Andrea Semplicini; Damiano Rizzoni; Ermanno Rossi; Marco Boscaro; Achille Cesare Pessina; Franco Mantero
Journal:  J Am Coll Cardiol       Date:  2006-11-13       Impact factor: 24.094

6.  K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

Authors:  Murim Choi; Ute I Scholl; Peng Yue; Peyman Björklund; Bixiao Zhao; Carol Nelson-Williams; Weizhen Ji; Yoonsang Cho; Aniruddh Patel; Clara J Men; Elias Lolis; Max V Wisgerhof; David S Geller; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Wenhui Wang; Tobias Carling; Richard P Lifton
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

7.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

Authors:  Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

8.  Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer.

Authors:  Einar Gudlaugsson; Ivar Skaland; Emiel A M Janssen; Rune Smaaland; Zhiming Shao; Anais Malpica; Feja Voorhorst; Jan P A Baak
Journal:  Histopathology       Date:  2012-09-11       Impact factor: 5.087

9.  Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: a population-based study from Western Norway.

Authors:  Thomas Arnesen; Nina Glomnes; Siri Strømsøy; Stian Knappskog; Anette Heie; Lars A Akslen; Marianne Grytaas; Jan Erik Varhaug; Oliver Gimm; Michael Brauckhoff
Journal:  Langenbecks Arch Surg       Date:  2013-06-19       Impact factor: 3.445

10.  Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer.

Authors:  Robin L Jones; Janine Salter; Roger A'Hern; Ash Nerurkar; Marina Parton; Jorge S Reis-Filho; Ian E Smith; Mitchell Dowsett
Journal:  Breast Cancer Res Treat       Date:  2009-02-27       Impact factor: 4.872

View more
  13 in total

Review 1.  The Potential Role of Aldosterone-Producing Cell Clusters in Adrenal Disease.

Authors:  Jung Soo Lim; William E Rainey
Journal:  Horm Metab Res       Date:  2020-03-30       Impact factor: 2.936

Review 2.  Primary aldosteronism diagnostics: KCNJ5 mutations and hybrid steroid synthesis in aldosterone-producing adenomas.

Authors:  Juilee Rege; Adina F Turcu; William E Rainey
Journal:  Gland Surg       Date:  2020-02

Review 3.  Developments in Primary Aldosteronism Subtyping Using Steroid Profiling.

Authors:  Taweesak Wannachalee; Adina F Turcu
Journal:  Horm Metab Res       Date:  2020-04-24       Impact factor: 2.936

4.  International Histopathology Consensus for Unilateral Primary Aldosteronism.

Authors:  Tracy Ann Williams; Celso E Gomez-Sanchez; William E Rainey; Thomas J Giordano; Alfred K Lam; Alison Marker; Ozgur Mete; Yuto Yamazaki; Maria Claudia Nogueira Zerbini; Felix Beuschlein; Fumitoshi Satoh; Jacopo Burrello; Holger Schneider; Jacques W M Lenders; Paolo Mulatero; Isabella Castellano; Thomas Knösel; Mauro Papotti; Wolfgang Saeger; Hironobu Sasano; Martin Reincke
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

5.  ACTH Stimulation Maximizes the Accuracy of Peripheral Steroid Profiling in Primary Aldosteronism Subtyping.

Authors:  Yuta Tezuka; Kae Ishii; Lili Zhao; Yuto Yamazaki; Ryo Morimoto; Hironobu Sasano; Aaron M Udager; Fumitoshi Satoh; Adina F Turcu
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 6.134

6.  Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma.

Authors:  Kelly De Sousa; Sheerazed Boulkroun; Stéphanie Baron; Kazutaka Nanba; Maxime Wack; William E Rainey; Angélique Rocha; Isabelle Giscos-Douriez; Tchao Meatchi; Laurence Amar; Simon Travers; Fabio L Fernandes-Rosa; Maria-Christina Zennaro
Journal:  Hypertension       Date:  2020-03-02       Impact factor: 10.190

7.  Histopathological Analysis of Tumor Microenvironment and Angiogenesis in Pheochromocytoma.

Authors:  Xin Gao; Yuto Yamazaki; Alessio Pecori; Yuta Tezuka; Yoshikiyo Ono; Kei Omata; Ryo Morimoto; Yasuhiro Nakamura; Fumitoshi Satoh; Hironobu Sasano
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-10       Impact factor: 5.555

Review 8.  Recent Development toward the Next Clinical Practice of Primary Aldosteronism: A Literature Review.

Authors:  Yuta Tezuka; Yuto Yamazaki; Yasuhiro Nakamura; Hironobu Sasano; Fumitoshi Satoh
Journal:  Biomedicines       Date:  2021-03-17

9.  The Genotype-Based Morphology of Aldosterone-Producing Adrenocortical Disorders and Their Association with Aging.

Authors:  Xin Gao; Yuto Yamazaki; Yuta Tezuka; Kei Omata; Yoshikiyo Ono; Ryo Morimoto; Yasuhiro Nakamura; Fumitoshi Satoh; Hironobu Sasano
Journal:  Endocrinol Metab (Seoul)       Date:  2021-02-24

10.  Cellular Senescence in Human Aldosterone-Producing Adrenocortical Cells and Related Disorders.

Authors:  Jacopo Pieroni; Yuto Yamazaki; Xin Gao; Yuta Tezuka; Hiroko Ogata; Kei Omata; Yoshikiyo Ono; Ryo Morimoto; Yasuhiro Nakamura; Fumitoshi Satoh; Hironobu Sasano
Journal:  Biomedicines       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.